Crescent Biopharma, Inc. (CBIO) at a glance

Crescent Biopharma, Inc. (CBIO) is a small-cap Healthcare company. It trades at $17.75, with a P/E of 2.6, a 0% profit margin and revenue decline of 90.4%. It pays a 934% dividend yield. Vestovix scores it 63/100 overall. Its strongest dimension is Income (97/100) and its weakest is Growth (12/100).

Price
$17.76
Market cap
$494.1M
P/E ratio
2.6
Dividend yield
934.00%
Beta
n/a
52-week range
$8.72 to $27.41
Vestovix Score63/ 100How this works
Value
92
Growth
12
Income
97
Safety
62
Momentum
48

Other Healthcare stocks

See all